Edition:
India

Intersect ENT Inc (XENT.OQ)

XENT.OQ on NASDAQ Stock Exchange Global Market

34.55USD
19 Jan 2018
Change (% chg)

$0.55 (+1.62%)
Prev Close
$34.00
Open
$34.10
Day's High
$34.95
Day's Low
$34.10
Volume
62,641
Avg. Vol
61,815
52-wk High
$35.25
52-wk Low
$11.75

Select another date:

Mon, Jan 8 2018

BRIEF-Intersect ENT Reports Preliminary Q4 And Year 2017 Revenue

* - CO CONTINUES TO EXPECT TO LAUNCH SINUVA COMMERCIALLY IN Q2 OF 2018

BRIEF-‍James Flynn​ reports 5.92 pct passive stake in Intersect ENT

* ‍James Flynn​ reports 5.92 percent passive stake in Intersect ENT as of Nov 6 - SEC filing Source text : (http://bit.ly/2jwmJXW) Further company coverage:

BRIEF-FDA performs pre-approval inspection of Intersect ENT's menlo park facility

* FDA performs pre-approval inspection of Intersect ENT's menlo park facility

BRIEF-Intersect ENT Inc reports Q3 revenue $22.3 million

* Intersect ENT Inc - ‍outlook for 2017 gross margin continues to be about 84%​

BRIEF-Intersect ENT qtrly net loss per share $0.08

* Q2 earnings per share view $-0.19 -- Thomson Reuters I/B/E/S

Select another date: